Intra-Cellular Therapies Inc (NASDAQ:ITCI)

Delayed Data
As of Aug 15
 -1.04 / -1.94%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for Intra-Cellular Therapies Inc have a median target of 70.00, with a high estimate of 90.00 and a low estimate of 57.00. The median estimate represents a +33.21% increase from the last price of 52.55.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Intra-Cellular Therapies Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.86%
Growthannually 8.48%


Growthquarterly 20.48%
Growthannually 183.28%
Key to the earnings and sales forecast charts.